Patient Recruitment and Late-Stage Research Companies Merge
Leading healthcare firms Blue Chip Patient Recruitment and J Trotter Research & Consulting combine to form Continuum Clinical.
Suburban Chicago-based healthcare firms Blue Chip Patient Recruitment (BCPR) and J Trotter Research & Consulting (JTRC) have merged to form Continuum Clinical. The new company combines the BCPR specialty of patient recruitment for clinical trials and the JTRC expertise of late-stage (post-approval) research, and will also offer medical communications services.
“Continuum Clinical is uniquely positioned in the market to provide three distinct, yet interrelated services to pharmaceutical and medical device companies,” said Jeff Trotter, the president of Continuum. “This new venture represents a convergence of services and robust capabilities that respond to the increasingly aligned needs of clinical researchers and product commercialization professionals.”
Continuum will capitalize on BCPR’s twenty years of experience recruiting patients for over 600 clinical trials, as well as its communication, public relations, digital, advertising and media buying capabilities. In addition, Continuum builds on JTRC’s thirty-year legacy in health economics and outcomes research, observational studies and patient registries, and an extensive track record of publications.
“We are excited to build upon our path of transformational growth by offering our current and potential clients even more depth of services,” said Neil Weisman, executive vice president and general manager of Continuum’s patient recruitment practice (which will retain the BCPR branding through 2014). “Our expanded platform will enhance our capabilities in both site and patient engagement in all phases of clinical research.”
By offering the three related services to major pharmaceutical and medical device clients, Continuum Clinical facilitates greater internal synergies and efficiencies in establishing and communicating the value of clients’ medical product innovations to physicians, patients, and payers.
“Our credentials with multiple stakeholders within our client companies is what sets us apart,” said Trotter. “And we are intimately familiar with both the challenges and the considerable opportunities that exist when commercial and clinical teams work together.”
The company will be headquartered in Northbrook, Ill., with staff located off-site in strategic locations globally.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
